Sonova Holding (OTCMKTS:SONVY - Get Free Report) shares crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $62.21 and traded as low as $59.02. Sonova shares last traded at $59.30, with a volume of 5,125 shares.
Analyst Upgrades and Downgrades
Several equities research analysts have recently issued reports on the company. Kepler Capital Markets upgraded Sonova from a "strong sell" rating to a "hold" rating in a report on Friday, June 6th. BNP Paribas cut shares of Sonova from a "strong-buy" rating to a "strong sell" rating in a research note on Wednesday, June 11th. Hsbc Global Res downgraded shares of Sonova from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, May 21st. Barclays downgraded shares of Sonova from a "hold" rating to a "strong sell" rating in a report on Friday, June 20th. Finally, HSBC lowered shares of Sonova from a "buy" rating to a "hold" rating in a research note on Wednesday, May 21st. Four research analysts have rated the stock with a sell rating and four have assigned a hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold".
View Our Latest Stock Analysis on SONVY
Sonova Price Performance
The firm has a 50-day moving average price of $62.21 and a two-hundred day moving average price of $62.96. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.27 and a quick ratio of 0.96.
Sonova Increases Dividend
The business also recently declared a dividend, which was paid on Wednesday, July 2nd. Shareholders of record on Tuesday, June 17th were issued a $0.6243 dividend. The ex-dividend date was Monday, June 16th. This is an increase from Sonova's previous dividend of $0.57. This represents a yield of 0.99%.
About Sonova
(
Get Free Report)
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sonova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.
While Sonova currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
